Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B

Systematic discontinuation of long‐term treatment with nucleos(t)ide analogues (NAs) is one strategy to increase functional cure rates in patients with chronic hepatitis B e antigen (HBeAg)–negative hepatitis B. Currently, available study results are heterogeneous; however, long‐term hepatitis B sur...

Descripción completa

Detalles Bibliográficos
Autores principales: van Bömmel, Florian, Berg, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485892/
https://www.ncbi.nlm.nih.gov/pubmed/34558833
http://dx.doi.org/10.1002/hep4.1708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485892/
https://www.ncbi.nlm.nih.gov/pubmed/34558833
http://dx.doi.org/10.1002/hep4.1708

Ejemplares similares